Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Pipeline™ Vantage Embolization Device With Shield Technology™ for Endovascular Treatment of Wide-Necked Intracranial Aneurysms

NCT03873714 is registered in ClinicalTrials.gov with Medtronic Neurovascular Clinical Affairs as lead sponsor.

NCT NCT03873714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03873714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Pipeline™ Vantage Embolization Device With Shield Technology™ for Endovascular Treatment of Wide-Necked Intracranial Aneurysms
Lead sponsor
Medtronic Neurovascular Clinical Affairs
Phase
Not applicable
Overall status
Terminated
Start date
April 2, 2020
Completion date
September 18, 2023
Enrollment
14 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial aneurysm